Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

January 3, 2026

Study Completion Date

January 3, 2026

Conditions
Plasma Cell Myeloma
Interventions
OTHER

Cessation of continuous matinenace therapy

Cessation of maintenance therapy for participants in sustained MRD-negative remission while under careful observation

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11553

Memorial Sloan Kettering Nassau, Uniondale

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

07748

Memorial Sloan Kettering Monmouth, Middletown

07645

Memorial Sloan Kettering Bergen, Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER